566 related articles for article (PubMed ID: 25107915)
1. Molecular pathways: linking tumor microenvironment to epithelial-mesenchymal transition in metastasis.
Jung HY; Fattet L; Yang J
Clin Cancer Res; 2015 Mar; 21(5):962-968. PubMed ID: 25107915
[TBL] [Abstract][Full Text] [Related]
2. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics.
Zhang J; Hu Z; Horta CA; Yang J
Semin Cancer Biol; 2023 Jan; 88():46-66. PubMed ID: 36521737
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.
Dominguez C; David JM; Palena C
Semin Cancer Biol; 2017 Dec; 47():177-184. PubMed ID: 28823497
[TBL] [Abstract][Full Text] [Related]
4. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
5. Tumor and its microenvironment: a synergistic interplay.
Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
[TBL] [Abstract][Full Text] [Related]
6. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
Li H; Xu F; Li S; Zhong A; Meng X; Lai M
Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
[TBL] [Abstract][Full Text] [Related]
7. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
8. Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy.
Chen J; Ding ZY; Li S; Liu S; Xiao C; Li Z; Zhang BX; Chen XP; Yang X
Theranostics; 2021; 11(3):1345-1363. PubMed ID: 33391538
[TBL] [Abstract][Full Text] [Related]
9. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.
Schliekelman MJ; Gibbons DL; Faca VM; Creighton CJ; Rizvi ZH; Zhang Q; Wong CH; Wang H; Ungewiss C; Ahn YH; Shin DH; Kurie JM; Hanash SM
Cancer Res; 2011 Dec; 71(24):7670-82. PubMed ID: 21987723
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
11. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced epithelial to mesenchymal transition in cancer.
Hapke RY; Haake SM
Cancer Lett; 2020 Sep; 487():10-20. PubMed ID: 32470488
[TBL] [Abstract][Full Text] [Related]
13. Autocrine Fibronectin Inhibits Breast Cancer Metastasis.
Shinde A; Libring S; Alpsoy A; Abdullah A; Schaber JA; Solorio L; Wendt MK
Mol Cancer Res; 2018 Oct; 16(10):1579-1589. PubMed ID: 29934326
[TBL] [Abstract][Full Text] [Related]
14. TGFβ and matrix-regulated epithelial to mesenchymal transition.
Moustakas A; Heldin P
Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.
Chen HT; Liu H; Mao MJ; Tan Y; Mo XQ; Meng XJ; Cao MT; Zhong CY; Liu Y; Shan H; Jiang GM
Mol Cancer; 2019 May; 18(1):101. PubMed ID: 31126310
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
18. Targeting EMT in Cancer with Repurposed Metabolic Inhibitors.
Ramesh V; Brabletz T; Ceppi P
Trends Cancer; 2020 Nov; 6(11):942-950. PubMed ID: 32680650
[TBL] [Abstract][Full Text] [Related]
19. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.
Yang JD; Nakamura I; Roberts LR
Semin Cancer Biol; 2011 Feb; 21(1):35-43. PubMed ID: 20946957
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of tumour microenvironment in the progression and development of oral cancer.
Mughees M; Sengupta A; Khowal S; Wajid S
Mol Biol Rep; 2021 Feb; 48(2):1773-1786. PubMed ID: 33492572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
